Early intravenous indomethacin prolongs respiratory support in very low birth weight infants

Acta paediatrica Scandinavica
M VincerA Fraser

Abstract

Infants weighing 1500 g at birth requiring either intermittent positive pressure ventilation or continuous positive airway pressure by 12 hours of age were entered in a randomized double blind controlled trial to test the efficacy of early intravenous indomethacin therapy in preventing chronic pulmonary disease of prematurity. Of the 30 newborns enrolled, 15 were treated with indomethacin and 15 were treated with placebo at 12, 24 and 36 hours of age. The groups were similar for birth weight, gestational age, sex, hyaline membrane disease and intracranial hemorrhage. Infants in the placebo group were successfully weaned from intermittent positive pressure ventilation at an earlier age than infants in the indomethacin group (p less than 0.05). Furthermore, chronic pulmonary disease of prematurity was similar in the two groups despite a reduction in the incidence of patent ductus arteriosus in the indomethacin group.

References

Oct 1, 1979·The Journal of Pediatrics·R F CifuentesS J Soldin
Feb 16, 1967·The New England Journal of Medicine·W H NorthwayD Y Porter

❮ Previous
Next ❯

Citations

Aug 18, 1995·Early Human Development·J T Wells, L R Ment
Jan 1, 1991·International Journal of Technology Assessment in Health Care·R I Clyman
Jan 1, 1991·Archives of Disease in Childhood·J M Rennie, R W Cooke
Mar 1, 1996·Archives of Disease in Childhood. Fetal and Neonatal Edition·P W Fowlie
Nov 7, 2003·Archives of Disease in Childhood. Fetal and Neonatal Edition·P W Fowlie, P G Davis
Jan 1, 1995·Journal of Perinatal Medicine·V ZanardoF Cantarutti
Feb 26, 2010·Journal of Perinatology : Official Journal of the California Perinatal Association·W E Benitz
Jul 11, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·C Hammerman, M Kaplan
Nov 1, 1993·Early Human Development·V Y Yu
Jun 1, 1992·Early Human Development·D B Knight
Oct 8, 2005·Biology of the Neonate·Eduardo BancalariAlvaro Gonzalez
Dec 1, 1991·Journal of Paediatrics and Child Health·V S Rajadurai, V Y Yu
Jan 1, 1990·Pediatric Pulmonology·E Bancalari, I Sosenko
Jul 9, 2010·The Cochrane Database of Systematic Reviews·Peter W FowlieWilliam McGuire
Feb 1, 1997·Journal of Paediatrics and Child Health·R K Kumar, V Y Yu
Oct 8, 2020·Journal of Perinatology : Official Journal of the California Perinatal Association·Meera N Sankar, William E Benitz
Mar 4, 2021·Seminars in Fetal & Neonatal Medicine·Koert de WaalMartin Kluckow

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.